While our analysis illustrates either modest or no improvement in survival associated with OFS in patients with ER+ premenopausal breast cancer, additional retrospective analyses are necessary to elucidate the prognosis and sequelae associated with BSO exclusively. Here, ESR1 is linked to breast cancer.